Board MeetingMay 7, 2026, 06:37 AM
Fennec Pharmaceuticals Q1 2026 Earnings Call Scheduled for May 14
AI Summary
Fennec Pharmaceuticals Inc. announced it will release its first quarter 2026 financial results on Thursday, May 14, 2026, before the U.S. financial markets open. Following the release, management will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial and business results. The company, a commercial stage specialty pharmaceutical firm, focuses on commercializing PEDMARK® to reduce ototoxicity in cancer patients.
Key Highlights
- Fennec Pharmaceuticals will release its first quarter 2026 financial results before U.S. market opening on Thursday, May 14, 2026.
- Management will host a conference call and webcast on May 14, 2026, at 8:30 a.m. Eastern Time.
- Webcast and participant links are provided for live access.
- A webcast replay will be archived on the company's website for thirty days.
Price Impact
More from FENC